Novartis to spend $300m on biotherapeutics drive
Swiss pharmaceutical company Novartis will create a $100 million biologics hub in Basel as part of a $300 million global investment in biotherapeutics.
Source: swissinfo.ch
Stay updated with breaking news from Technical Research Division. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Swiss pharmaceutical company Novartis will create a $100 million biologics hub in Basel as part of a $300 million global investment in biotherapeutics.
The new Metal 3 API, coming later this year, will allow Macs to upscale more efficiently, intelligently draw frames for smoother gameplay, and access game data quicker.